Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 20, 2025

1/23/25 4:15:00 PM ET

Hospital/Nursing Management

Health Care

Get the next $SEM alert in real time by email

MECHANICSBURG, Pa., Jan. 23, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and year ended December 31, 2024 on Thursday, February 20, 2025 after the market closes.

Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 21, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link.

For listeners wishing to dial-in via telephone, or participate in the question and answer session, you may pre-register for the call at Select Medical Earnings Call Registration to obtain your dial-in number and unique passcode for the call.

Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on the number of facilities. Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, and the outpatient rehabilitation segment. As of December 31, 2024, Select Medical operated 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics in 39 states and the District of Columbia. At December 31, 2024, Select Medical had operations in 41 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

Investor inquiries:

Joel T. Veit

Senior Vice President and Treasurer

717-972-1100

[email protected]

View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-to-announce-fourth-quarter-and-full-year-2024-results-on-thursday-february-20-2025-302358570.html

SOURCE Select Medical Holdings Corporation

Get the next $SEM alert in real time by email

Date	Price Target	Rating	Analyst
4/16/2025	$25.00	Outperform	Mizuho
2/24/2025	$23.00	Hold → Buy	The Benchmark Company
11/25/2024		Buy → Hold	The Benchmark Company
8/20/2024	$42.00	Buy	BofA Securities
3/7/2022	$47.00 → $42.00	Outperform	RBC Capital
1/18/2022	$40.00 → $35.00	Buy	B of A Securities
1/18/2022	$50.00 → $47.00	Outperform	RBC Capital
8/10/2021	$37.00 → $39.00	Neutral	Credit Suisse

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 20, 2025

Chat with this insight

Recent Analyst Ratings for
$SEM

$SEM
SEC Filings

Select Medical Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

SEC Form 10-Q filed by Select Medical Holdings Corporation

Select Medical Holdings Corporation filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

$SEM
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 20, 2025

Chat with this insight

Recent Analyst Ratings for $SEM

$SEM SEC Filings

Select Medical Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

SEC Form 10-Q filed by Select Medical Holdings Corporation

Select Medical Holdings Corporation filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

$SEM Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

Recent Analyst Ratings for
$SEM

$SEM
SEC Filings

$SEM
Insider Purchases